Drug Patents owned by Hikma
1. List of Kloxxado drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10973814 | HIKMA | Liquid naloxone spray |
Aug, 2034
(11 years from now) | |
| US10722510 | HIKMA | Liquid naloxone spray |
Aug, 2034
(11 years from now) | |
| US11135155 | HIKMA | Liquid naloxone spray |
Aug, 2034
(11 years from now) | |
Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient
Market Authorisation Date: 29 April, 2021
Treatment: Use of naloxone for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients
Dosage: SPRAY;NASAL
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic